Latest Applied genetics Stories
Targeted Genetics Corporation (NASDAQ: TGEN) will report its second quarter 2008 financial results before the open of the financial markets on Wednesday, August 6, 2008. Following the announcement, management will host a conference call and webcast discussion of the financial results and provide a general corporate update beginning at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time. You may access the live webcast via the "Events" section found on the homepage of the Company's website at:...
No gene therapy for athletes allowed in China: Ministry of Health BEIJING, July 24 (Xinhua) -- China has never given approval to any hospital to offer performance-enhancing stem-cell therapy, an official with the Ministry of Health said here on Thursday. The official made the remarks in response to a German TV report that some Chinese hospitals offer what is described as performance- enhancing gene therapy treatment. "China has never allowed medical institutions or staff to provide...
By Report by Paul Vallely BUT HOW ACCURATE ARE THEY? AND HOW MUCH DO YOU REALLY WANT TO KNOW? AROUND 2 PER CENT OF THE POPULATION WILL SUFFER FROM BIPOLAR DISORDER AT SOME POINT IN THEIR LIVES. That doesnt sound much. But what if there were a test which would tell you that you were likely to be one of those who will go on to develop it. Would you take it? It may sound like the far realms of science fiction but a company in the United States called Psynomics Incorporated claims to have...
Warnex Inc. (TSX: WNX) announced today the launch of its new website www.prodna.ca for its DNA identification tests, including the PRO-DNA(TM) Paternity Test. PRO-DNA identification tests offer a clear, unequivocal answer. Using advanced DNA technology and validated procedures, Warnex offers identification tests of superior quality and reliability while using a simple, painless type of sampling procedure that can be performed easily at home. In addition to the paternity test, Warnex offers...
Officials are cracking down on companies that directly sell consumers genetic tests, threatening one of the fastest-growing parts of the U.S. biotech industry. In California, the Department of Public Health sent cease-and-desist letters to 13 companies two weeks ago, telling them they could not solicit business from state residents. The state of New York sent letters to 31 genetic testing companies since November, saying they need licenses to solicit DNA specimens from its residents. The...
AVI BioPharma, Inc. (NASDAQ: AVII) today announced that its partner in its cardiovascular program, Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal stent. The device, the Global Therapeutics GTX Coronary Stent System, is also the platform for a breakthrough drug-eluting stent (DES) technology which utilizes AVI-5126, developed by AVI. The drug candidate is an improved version of antisense gene therapy to inhibit the...
By MADONNA YANCEY, Courier & Press correspondent Did your father and grandfather have high blood pressure? Have several men in your family died of heart disease at an early age? What about the women in your family? Has your mother, grandmother or an aunt developed breast cancer? Does either of your parents or grandparents have diabetes? The answers to these questions may hold the key to your medical future. Your children's, too. Our genetic makeup determines our physical characteristics...
A recent study conducted by US researchers revealed that gene therapy could result in recession of a rare neurological disorder in children.Although lead researcher Dr. Ron Crystal of New York-Presbyterian Hospital/Weill Cornell Medical Center said the team of researchers was "encouraged by the study's results. "It's not a cure."Late infantile neuronal ceroidlipofuscinosis, or LINCL, is a neurodegenerative disease that affects the central nervous system in children. The disease usually...
The recent successful treatment of a rare type of inherited blindness through gene therapy has increased optimism for some scientists who were beginning to lose faith in the dwindling field of gene repair technology.Signs of the rare disorder, known as Leber congenital amaurosis (LCA), usually become prevalent in early childhood. LCA damages the light receptors in the retina, which causes blindness by age 30.Damage in a gene called RPE65 is known as the root cause of LCA.Two research groups...
By Niklas Pollard STOCKHOLM (Reuters) - International Olympic Committee (IOC) president Jacques Rogge has called for new regulations against changing genes to increase athletic performance, so-called gene doping. Rogge said progress in the field of genetics now made it possible for the World Anti-Doping Agency (WADA), which held a conference here on gene therapy and doping with around 50 scientists and sports officials, to start formulating rules. "I am getting more and more anxious...
